相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of Oxidative Stress in the Genesis of Ventricular Arrhythmias
Adriana Adameova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mechanisms involved in adenosine pharmacological preconditioning-induced cardioprotection
Lovedeep Singh et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2018)
Myocardial Remodeling in Hypertension: Toward a New View of Hypertensive Heart Disease
Arantxa Gonzalez et al.
HYPERTENSION (2018)
Exosomes exert cardioprotection in dystrophin-deficient cardiomyocytes via ERK1/2-p38/MAPK signaling
Melanie Gartz et al.
SCIENTIFIC REPORTS (2018)
p38 MAPK in cardioprotection - are we there yet?
E. D. Martin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection
Xiu-Fang Gao et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Right ventricular hypertrophy and failure abolish cardioprotection by ischaemic pre-conditioning
Asger Andersen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Role of p38 inhibition in cardiac ischemia/reperfusion injury
Sarawut Kumphune et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Burn-induced apoptosis of cardiomyocytes is survivin dependent and regulated by PI3K/Akt, p38 MAPK and ERK pathways
Wei Cao et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
The p38 mitogen-activated protein kinase pathway-A potential target for intervention in infarction, hypertrophy, and heart failure
Michael S. Marber et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Adenosine A1 and A3 receptor agonists reduce hypoxic injury through the involvement of P38 MAPK
D. Leshem-Lev et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale
Beth A. Rose et al.
PHYSIOLOGICAL REVIEWS (2010)
Mechanisms of the Beneficial Actions of Ischemic Preconditioning on Subcellular Remodeling in Ischemic-Reperfused Heart
Alison L. Mueller et al.
CURRENT CARDIOLOGY REVIEWS (2010)
p38-MAPK is involved in restoration of the lost protection of preconditioning by nicorandil in vivo
Efstathios K. Iliodromitis et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Molecular mechanism of preconditioning
Manika Das et al.
IUBMB LIFE (2008)
Preconditioning in humans
Shereif H. Rezkalla et al.
HEART FAILURE REVIEWS (2007)
Creatine kinase activity is associated with blood pressure
Lizzy M. Brewster et al.
CIRCULATION (2006)
MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine
Yan-Jun Xu et al.
CARDIOVASCULAR RESEARCH (2006)
Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK
JA Moolman et al.
CARDIOVASCULAR DRUGS AND THERAPY (2006)
Mitogen-activated protein kinases:: A new therapeutic target in cardiac pathology
T Ravingerová et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts
W Hayashida et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Status of myocardial antioxidants in ischemia-reperfusion injury
NS Dhalla et al.
CARDIOVASCULAR RESEARCH (2000)
Role of oxidative stress in cardiovascular diseases
NS Dhalla et al.
JOURNAL OF HYPERTENSION (2000)
Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death
M Barancik et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)
分享论文
